The AVMA supports and encourages the ethical use of biotechnology in veterinary medicine to develop new or improved biologic and therapeutic agents. Such use may include but is not limited to:

• Internationally harmonized research, development, production, licensure/approval, sale, distribution, and use of safe and effective vaccines, pharmaceuticals, and other therapeutic products used in animal health.
• Science-based regulatory policies and procedures supporting pre and post-approval product evaluations.
• Development of innovative, useful (sensitive, specific, and robust) diagnostic and surveillance tools.